Home › Funds › STEMPOINT CAPITAL LP › SRRK
STEMPOINT CAPITAL LP position in SRRK
SCHOLAR ROCK HLDG CORP · Health Care
STEMPOINT CAPITAL LP reported holding 688,954 shares of SRRK (SCHOLAR ROCK HLDG CORP) in its Q3 2026 13F filing — a position valued at US$33.3M, representing 6.69% of its reported portfolio and ranking #1 among its reported holdings. STEMPOINT CAPITAL LP has disclosed SRRK holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How STEMPOINT CAPITAL LP's SRRK position evolved
STEMPOINT CAPITAL LP first disclosed a stake in SRRK in Q4 2024 at 100,000 shares (US$228K). The position peaked in Q3 2026 at 688,954 shares, worth US$33.3M. Across 8 filings, STEMPOINT CAPITAL LP increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 688,954 shares valued at US$33.3M — an increase of 449,808 shares quarter over quarter.. Notable position changes include a 466% increase in Q1 2025 (shares rose 10% over the following quarter), a 1405% increase in Q4 2025 (shares rose 12% over the following quarter), a 188% increase in Q3 2026 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 100.00K | $227.50K | New |
| Q1 2025 | 566.21K | $18.20M | Add |
| Q2 2025 | 528.12K | $18.71M | Reduce |
| Q3 2025 | 18.40K | $23.92K | Reduce |
| Q4 2025 | 277.00K | $484.75K | Add |
| Q1 2026 | 100.00K | $588.00K | Reduce |
| Q2 2026 | 239.15K | $13.15M | Add |
| Q3 2026 | 688.95K | $33.29M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SRRK and 13F data
SRRK (SCHOLAR ROCK HLDG CORP) is a Health Care company. 48 other funds we track also report a position in SRRK — the largest reported positions include Siren, L.L.C. (US$453.0M), Samsara BioCapital, LLC (US$379.4M), Orbis Allan Gray Ltd (US$293.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SRRK
- Siren, L.L.C. 9.38M sh · $453.00M · Q3 2026
- Samsara BioCapital, LLC 6.90M sh · $379.37M · Q2 2026
- Orbis Allan Gray Ltd 6.08M sh · $293.56M · Q3 2026
- Redmile Group, LLC 4.31M sh · $237.11M · Q2 2026
- Bellevue Group AG 2.45M sh · $134.73M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 2.32M sh · $112.13M · Q3 2026
- Hood River Capital Management LLC 2.25M sh · $108.81M · Q3 2026
- EVENTIDE ASSET MANAGEMENT, LLC 2.08M sh · $100.40M · Q3 2026
- Integral Health Asset Management, LLC 1.25M sh · $60.64M · Q3 2026
- Casdin Capital 665.00K sh · $36.58M · Q2 2026
- Rock Springs Capital Management LP 682.65K sh · $32.99M · Q3 2026
More on STEMPOINT CAPITAL LP
FAQ
How long has STEMPOINT CAPITAL LP held SRRK?
STEMPOINT CAPITAL LP has disclosed SRRK holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is STEMPOINT CAPITAL LP's current position in SRRK?
As of Q3 2026, STEMPOINT CAPITAL LP holds 688.95K shares of SRRK (SCHOLAR ROCK HLDG CORP), valued at $33.29M, representing 6.69% of its reported portfolio and ranking #1.
Has STEMPOINT CAPITAL LP been buying or selling SRRK?
In the latest 13F filing (Q3 2026), STEMPOINT CAPITAL LP increased its position in SRRK. The position peaked in Q3 2026 at 688.95K shares.
Which other funds hold SRRK?
Other major institutional holders of SRRK include Siren, L.L.C., Samsara BioCapital, LLC, Orbis Allan Gray Ltd, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.